Molecular Alterations of Endometrial Cancer
A special issue of Cancers (ISSN 2072-6694). This special issue belongs to the section "Molecular Cancer Biology".
Deadline for manuscript submissions: 20 August 2024 | Viewed by 1676
Special Issue Editors
Interests: endometrial cancer; molecular alterations; patients prognosis; endometrial hyperplasia
2. GROW—School for Oncology and Reproduction, Maastricht University, 6202 AZ Maastricht, The Netherlands
Interests: endometrial cancer; molecular alterations; patient prognosis; hormonal interactions
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Several pieces of data presented up to now have suggested a great influence of various genetic alterations during the development and subsequent spread of female genital tract carcinomas. Endometrial cancer (EC) is one of the leading female genital tract neoplasms worldwide, with over 400,000 new cases diagnosed annually worldwide. Unfortunately, both its incidence and mortality are slightly increasing. Molecular classification presented a few years ago identified four district subgroups of EC with various genetic/immunohistochemical alterations. This classification also has several clinical applications, both in treatment protocols as well as patient outcomes. Presently, we would like to invite all scientists investigating the role of molecular alterations in EC to share their results and knowledge by submitting their manuscripts to this Special Issue of the prestigious Cancers journal, entitled “Molecular Alterations of Endometrial Cancer”. The editors will do their best in fairly pre-reviewing all submissions, giving the chance to review and subsequently quickly publish the manuscripts with outstanding scientific achievements.
Prof. Dr. Andrzej Semczuk
Dr. Andrea Romano
Guest Editors
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Cancers is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2900 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- endometrial cancer
- molecular alterations
- molecular classification
- patient outcomes
- endometrial hyperplasia
- targeted therapy
- genetic pathway
- endometrial cancer subtypes
